Business Description
Cellectis SA
ISIN : US15117K1034
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.99 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | -1.22 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.26 | |||||
Beneish M-Score | -3.99 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -77 | |||||
3-Year EBITDA Growth Rate | -21.1 | |||||
3-Year EPS without NRI Growth Rate | -44.9 | |||||
3-Year FCF Growth Rate | 44.4 | |||||
3-Year Book Growth Rate | -41.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 78 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 370.34 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.44 | |||||
9-Day RSI | 42.86 | |||||
14-Day RSI | 47.72 | |||||
6-1 Month Momentum % | -22.07 | |||||
12-1 Month Momentum % | 13.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.92 | |||||
Quick Ratio | 1.92 | |||||
Cash Ratio | 1.71 | |||||
Days Sales Outstanding | 151.82 | |||||
Days Payable | 19460.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.8 | |||||
Shareholder Yield % | -59.24 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97.32 | |||||
Operating Margin % | -677.48 | |||||
Net Margin % | -613.34 | |||||
FCF Margin % | 391.54 | |||||
ROE % | -80.49 | |||||
ROA % | -26.09 | |||||
ROIC % | -46.16 | |||||
3-Year ROIIC % | -77.55 | |||||
ROC (Joel Greenblatt) % | -102.1 | |||||
ROCE % | -48.35 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 5.26 | |||||
PS Ratio | 15.54 | |||||
PB Ratio | 1.46 | |||||
Price-to-Tangible-Book | 1.45 | |||||
Price-to-Free-Cash-Flow | 3.33 | |||||
Price-to-Operating-Cash-Flow | 3.37 | |||||
EV-to-EBIT | -0.4 | |||||
EV-to-EBITDA | -0.5 | |||||
EV-to-Revenue | 2.91 | |||||
EV-to-Forward-Revenue | 12.04 | |||||
EV-to-FCF | 0.81 | |||||
Price-to-Net-Current-Asset-Value | 4.5 | |||||
Price-to-Net-Cash | 15.75 | |||||
Earnings Yield (Greenblatt) % | -249.42 | |||||
FCF Yield % | 23.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cellectis SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 12.06 | ||
EPS (TTM) (€) | -1.33 | ||
Beta | 3.83 | ||
Volatility % | 184.35 | ||
14-Day RSI | 47.72 | ||
14-Day ATR (€) | 0.088648 | ||
20-Day SMA (€) | 1.9495 | ||
12-1 Month Momentum % | 13.07 | ||
52-Week Range (€) | 0.895 - 3.18 | ||
Shares Outstanding (Mil) | 100.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cellectis SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cellectis SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cellectis SA Frequently Asked Questions
What is Cellectis SA(STU:ZVAA)'s stock price today?
When is next earnings date of Cellectis SA(STU:ZVAA)?
Does Cellectis SA(STU:ZVAA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |